AA
Altay, Ahmet
9 yayın · 108 atıf · 2021–2026
Yayın
9
Atıf
108
Yıllar
6
Yayınlar
| Başlık | Yıl | Tip | Atıf |
|---|---|---|---|
|
Pro-oxidant effect of lobaric acid as a therapeutic strategy against breast cancer: a molecular perspective
|
2026 | Article | 0 |
|
Lobaric Acid Exhibits Anticancer Potential by Modulating the Wnt/β-Catenin Signaling Pathway in MCF-7 Cells
|
2025 | Article | 1 |
|
Inhibition of thioredoxin reductase 1 by evernic and vulpinic acids: a promising anticancer strategy on A549 cells
|
2025 | Article | 2 |
|
Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1
|
2024 | Article | 9 |
|
Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells
|
2023 | Article | 12 |
|
Effect of evernic acid on human breast cancer MCF-7 and MDA-MB-453 cell lines via thioredoxin reductase 1: A molecular approach
|
2023 | Article | 16 |
|
Inhibition of thioredoxin reductase 1 by vulpinic acid suppresses the proliferation and migration of human breast carcinoma
|
2022 | Article | 23 |
|
Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells
|
2022 | Article | 23 |
|
<i>In</i> <i>vitro</i> Antioxidant and Cytotoxic Activities of Extracts of Endemic <i>Tanacetum erzincanense</i> Together with Phenolic Content by LC-ESI-QTOF-MS
|
2021 | Article | 22 |